Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats.

Saeed Shanehsazzadeh

Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats.

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Nuclear Medicine Communications
Publication status	Published - 2015

Cite this

@article{c10772b362ce4ff6bf678658bb199534,

title = "Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats.",

author = "Saeed Shanehsazzadeh",

year = "2015",

language = "English",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",

publisher = "Lippott Williams & Wilkins",

}

TY - JOUR

T1 - Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats.

AU - Shanehsazzadeh, Saeed

PY - 2015

Y1 - 2015

UR - http://pdfs.journals.lww.com/nuclearmedicinecomm/9000/00000/Assessment_of_the_effective_absorbed_dose_of.99130.pdf

M3 - Article

SN - 0143-3636

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

ER -

Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl) piperidine in humans on the basis of biodistribution data of rats.

Other files and links

Cite this